ArticleAmerican journal of cancer research2020

CDK9 inhibitor CDKI-73 is synergetic lethal with PARP inhibitor olaparib in BRCA1 wide-type ovarian cancer.

Jiajia Li et al.PubMed ↗Full text ↗

No numbers read from the abstract.